Abstract
Background
“Shoulder” pancreatic cancer, defined as tumor located at the confluence where the splenic vein meets the portal vein, has specific adjacent anatomies. It’s difficult to resect this type of tumor with adequate regional lymphadenectomy.
Methods
We described a new concept of “shoulder” pancreatic cancer, and retrospectively analyzed eleven consecutive cases from September 2019 to April 2020, to assess the safety and efficacy of the retrograde artery first approach in minimally invasive distal pancreatectomy. The primary outcome was set as radical (R0) resection rate.
Results
All of the 11 cases achieved R0 resection, with a median of 8 (range 5–32) lymph nodes harvested, given the ratio of embraced splenic vein in 72.7% of the cases, splenic artery embracement in 45.5%, and SMV–PV wall invasion in 27.3%. The maximum tumor size on pathology was 35 (range 20–65) mm. The median operative time was 260 (range 155–470) min, and the median estimated blood loss was 200 (range 50–1000) ml. One case needed intraoperative transfusion. One grade B postoperative pancreatic fistula occurred accompanied with abdominal infection, while the rest of cases recovered uneventful. The median postoperative length of stay was 9 (range 6–20) days.
Conclusions
“Shoulder” pancreatic cancers are clinically significant. Retrograde artery first approach is a potentially safe and effective alternative to achieve a radical resection margin for shoulder pancreatic cancers in minimally invasive era. More evidences are needed in the future.
Similar content being viewed by others
References
Tomasello G, Ghidini M, Costanzo A, Ghidini A, Russo A, Barni S, Passalacqua R, Petrelli F (2019) Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastro Oncol 10:259–269
Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133:521–527
Schlitter AM, Esposito I (2010) Definition of microscopic tumor clearance (R0) in pancreatic cancer resections. Cancers (Basel) 2:2001–2010
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591
Healy JM, Kunstman JW, Salem RR (2015) Proposal and critical appraisal of exclusion criteria to the international study group for pancreatic surgery definition of delayed gastric emptying. J Am Coll Surg 220:1036–1043
Correa-Gallego C, Brennan MF, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ (2012) Contemporary experience with postpancreatectomy hemorrhage: results of 1122 patients resected between 2006 and 2011. J Am Coll Surg 215:616–621
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
Sawyer R (2018) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 378:686
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg 240:205–213
Lof S, Moekotte AL, Al-Sarireh B, Ammori B, Aroori S, Durkin D, Fusai GK, French JJ, Gomez D, Marangoni G, Marudanayagam R, Soonawalla Z, Sutcliffe R, White SA, Abu Hilal M, Spolentini G, Heijde N, Kanwar A, Schlegel A, Mowbray NG, Rahman S, Kabir I, Deakin M, Bowling K, Khaled Y (2019) Multicentre observational cohort study of implementation and outcomes of laparoscopic distal pancreatectomy. Br J Surg 106:1657–1665
Dai MH, Shi N, Xing C, Liao Q, Zhang TP, Chen G, Wu WM, Guo JC, Liu ZW, Zhao YP (2017) Splenic preservation in laparoscopic distal pancreatectomy. Br J Surg 104:452–462
de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal Md, Busch O, Besselink M (2019) Minimally invasive versus open distal pancreatectomy (LEOPARD). Ann Surg 269:2–9
Alfieri S, Boggi U, Butturini G, Pietrabissa A, Morelli L, Di Sebastiano P, Vistoli F, Damoli I, Peri A, Lapergola A, Fiorillo C, Panaccio P, Pugliese L, Ramera M, De Lio N, Di Franco G, Rosa F, Menghi R, Doglietto GB, Quero G (2020) Full robotic distal pancreatectomy: safety and feasibility analysis of a multicenter cohort of 236 patients. Surg Innov 27:11–18
Hong S, Song KB, Madkhali AA, Hwang K, Yoo D, Lee JW, Youn WY, Alshammary S, Park Y, Lee W, Kwon J, Lee JH, Hwang DW, Kim SC (2019) Robotic versus laparoscopic distal pancreatectomy for left-sided pancreatic tumors: a single surgeon's experience of 228 consecutive cases. Surg Endosc. https://doi.org/10.1007/s00464-019-07047-8
Wu WM, Jin G, Wang CY, Miao Y, Wang HZ, Lou WH, Yu XJ, Sun B, Li HM, Qin RY, Wu Z, Wang WL, Xu K, Wang L, Liang TB, Hao CY, Huang HG, Li YX, Tan G, Zhao YG, Hao JH, Wang YF, Peng CH, Liu XB, Ou JR, Yuan CH, Wang XF, Yang YM, Cai SW, Guo KJ, Jiang JX, Yu X, Wei JM, Li F, Wu XM, Zhao YP (2019) Pancreatic surgery study group of Chinese society of surgery of Chinese medical association. The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study. J Pancreatol 2:16–21
Rebelo A, Michalski CW, Ukkat J, Kleeff J (2019) Pancreatic cancer surgery with vascular resection. J Pancreatol 2:1–5
Hirono S, Kawai M, Okada K-i, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yamaue H (2016) Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis. Surgery 159:426–440
Funding
This study was supported by the National Natural Science Foundation of China (Grant No. 81972324), and the China Academy of Medical Sciences Innovation Fund for Medical Sciences (Grant No. 2016-I2M-3‐019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Feng Tian, Meng-qing Sun, Jun Lu, and Jun-chao Guo have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary video1 (MP4 120673 kb)
Rights and permissions
About this article
Cite this article
Tian, F., Sun, Mq., Lu, J. et al. Retrograde artery first approach for “shoulder” pancreatic cancers in minimally invasive distal pancreatectomy. Surg Endosc 35, 74–80 (2021). https://doi.org/10.1007/s00464-020-07908-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07908-7